$8.22
1.66% today
NYSE, Sep 16, 08:16 pm CET
ISIN
US87918A1051
Symbol
TDOC

Teladoc Inc Stock price

$8.09
+1.12 16.07% 1M
-7.05 46.57% 6M
-13.46 62.46% YTD
-13.81 63.06% 1Y
-131.20 94.19% 3Y
-62.30 88.51% 5Y
-20.41 71.61% 10Y
NYSE, Closing price Fri, Sep 13 2024
+0.47 6.17%
ISIN
US87918A1051
Symbol
TDOC
Sector

Key metrics

Market capitalization $1.39b
Enterprise Value $1.81b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 5.61
EV/Sales (TTM) EV/Sales 0.69
P/S ratio (TTM) P/S ratio 0.53
P/B ratio (TTM) P/B ratio 0.92
Revenue growth (TTM) Revenue growth 3.10%
Revenue (TTM) Revenue $2.61b
EBIT (operating result TTM) EBIT $-214.68m
Free Cash Flow (TTM) Free Cash Flow $323.03m
Cash position $1.16b
EPS (TTM) EPS $-5.93
P/E forward negative
P/S forward 0.54
EV/Sales forward 0.71
Short interest 20.47%
Show more

Is Teladoc Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,912 stocks worldwide.

Teladoc Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

28 Analysts have issued a Teladoc Inc forecast:

7x Buy
25%
20x Hold
71%
1x Sell
4%

Analyst Opinions

28 Analysts have issued a Teladoc Inc forecast:

Buy
25%
Hold
71%
Sell
4%

Financial data from Teladoc Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
2,609 2,609
3% 3%
100%
- Direct Costs 1,148 1,148
11% 11%
44%
1,461 1,461
2% 2%
56%
- Selling and Administrative Expenses 945 945
18% 18%
36%
- Research and Development Expense 332 332
4% 4%
13%
184 184
2,813% 2,813%
7%
- Depreciation and Amortization 398 398
83% 83%
15%
EBIT (Operating Income) EBIT -215 -215
4% 4%
-8%
Net Profit -1,006 -1,006
75% 75%
-39%

In millions USD.

Don't miss a Thing! We will send you all news about Teladoc Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Teladoc Inc Stock News

Positive
Seeking Alpha
one day ago
Teladoc's stock fell ~97% from its peak, but recent changes, including a new CEO, present a high-risk, high-reward opportunity. Positive year-over-year trends in integrated care members and chronic care enrollment, but effective monetization of these members remains a challenge. However, Teladoc's strong FCF and cheap valuation, trading at 4-5 times FCF, make it a potential turnaround candidate.
Neutral
GlobeNewsWire
10 days ago
PURCHASE, NY, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today announced that it issued an inducement award to a new employee.
Neutral
PYMNTS
27 days ago
Teladoc Health boasts substantial strengths and is positioned for enhanced performance, but according to new CEO Chuck Divita, there is work to do.
More Teladoc Inc News

Company Profile

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002 by George Byron Brooks and is headquartered in Purchase, NY.

Head office United States
CEO Charles Divita
Employees 5,600
Founded 2002
Website www.teladochealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today